Devdatt Kurdikar's Insider Trades & SAST Disclosures
Devdatt Kurdikar's most recent trade in Embecta Corp was a trade of 39,592 Common Stock done at an average price of $12 . Disclosure was reported to the exchange on April 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Devdatt Kurdikar.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.00 per share. | 04 Apr 2025 | 39,592 | 499,582 | - | 12 | 475,104 | Common Stock |
| Zimmer Biomet Holdings Inc | Devdatt Kurdikar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 122 | 507 | - | - | Phantom Stock Units | |
| Zimmer Biomet Holdings Inc | Devdatt Kurdikar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 130 | 384 | - | - | Phantom Stock Units | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 187,166 | 580,195 | - | 0 | Common Stock | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.70 per share. | 26 Nov 2024 | 48,956 | 531,239 | - | 18.7 | 915,477 | Common Stock |
| Zimmer Biomet Holdings Inc | Devdatt Kurdikar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 127 | 254 | - | - | Phantom Stock Units | |
| Zimmer Biomet Holdings Inc | Devdatt Kurdikar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 126 | 126 | - | - | Phantom Stock Units | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.78 per share. | 04 Apr 2024 | 4,535 | 388,005 | - | 12.8 | 57,957 | Common Stock |
| Embecta Corp | Kurdikar Devdatt | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.26 per share. | 11 Feb 2024 | 17,165 | 389,940 | - | 16.3 | 279,103 | Common Stock |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 21.81 per share. | 10 Aug 2023 | 5,000 | 244,791 | - | 21.8 | 109,050 | Common Stock |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.36 per share. | 04 Apr 2023 | 4,535 | 239,791 | - | 27.4 | 124,078 | Common Stock |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.51 per share. | 11 Feb 2023 | 2,109 | 244,326 | - | 28.5 | 60,128 | Common Stock |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 83,233 | 250,863 | - | 0 | Common Stock | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 26 Nov 2022 | 4,428 | 246,435 | - | 33.0 | 146,301 | Common Stock |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 217,799 | 558,963 | - | - | Stock Appreciation Rights | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Apr 2022 | 208,293 | 341,164 | - | - | Stock Appreciation Rights | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 01 Apr 2022 | 132,871 | 132,871 | - | - | Stock Appreciation Rights | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 132,004 | 690,967 | - | - | Stock Appreciation Rights | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 71,250 | 139,977 | - | 0 | Common Stock | |
| Embecta Corp | Devdatt Kurdikar | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 27,653 | 167,630 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges